If this feed-forward pathway for hyperglycemia-driven OGT activation is true, it might be applied to explain higher levels of OGT expression in other forms of cancer [70], including other non-TNBC subtypes of breast cancer, though we have not yet pursued this avenue of inquiry. The gene discussed is OGT; the disease is cancer.